
Sales for chronic hepatitis B therapeutics 2014 and 2024 by major market
This statistic shows the chronic hepatitis B therapeutics sales in 2014 and 2024, by major market. Sales for chronic hepatitis B therapeutics in the U.S. market were some 773 million U.S. dollars in 2014.